Skip to main content


Successful trials point to possible vaccine against AIDS

Combination of two previously unsuccessful vaccines makes researchers hopeful

After a long period of trial and failure, scientists now believe a licensed vaccine is within reach to prevent the AIDS virus. Scientists have been working on a vaccine for nearly three decades, but it wasn't until RV144, the 2009 clinical trial involving more than 16,000 adults in Thailand, that any significant progress had been reported.

Unlike other viruses, HIV is a moving target, constantly spitting out slightly different versions of itself, with different strains affecting different populations around the world.

Unlike other viruses, HIV is a moving target, constantly spitting out slightly different versions of itself, with different strains affecting different populations around the world.

LOS ANGELES, CA (Catholic Online) - Ironically, the test of a combination of two vaccines followed several big failures. Adding to the general surprise was the fact that Merck's vaccine may have actually increased the risk of infection among men who were both uncircumcised and had prior exposure to the virus used in the vaccine.

"It had an extremely chilling effect on the whole field," Colonel Nelson Michael says, the director of the U.S. Military HIV Research Program.

The Thai study tested Sanofi's ALVAC, a weakened canary pox virus used to sneak three HIV genes into the body, and AIDSVAX, that carried an HIV surface protein.

Both vaccines had very poor showings in individual trials to the point where 22 scientists wrote an editorial in the journal "Science" denouncing it as a waste of money.

And then researchers were pleasantly surprised when the results of the study published in 2009 showed the vaccine combination cut HIV infections by 31.2 percent. The impact upon researchers was huge.

It had taken several years to dispel the series of failed attempts, punctuated by a 2007 trial in which a Merck vaccine appeared to make people more vulnerable to infection, not less - that previously cast a shadow over AIDS vaccine research.

The 2009 clinical trial in Thailand was the very first to show it was possible to prevent HIV infection in humans. Discoveries afterwards have led to even more powerful vaccines using HIV-fighting antibodies.

As many as 34 million people are infected with HIV worldwide and with 2.7 million new infections in 2010 alone; experts say a vaccine is still the best hope for conquering AIDS.

Unlike other viruses, HIV is a moving target, constantly spitting out slightly different versions of itself, with different strains affecting different populations around the world.

New infections have fallen by 21 percent since the height of the pandemic in 1997.

Teams have been working on a vaccine for nearly three decades, but it wasn't until RV144, the 2009 clinical trial involving more than 16,000 adults in Thailand, that researchers achieved any hint of success.

© 2012, Catholic Online. Distributed by NEWS CONSORTIUM.

- - -

Pope Benedict XVI's Prayer Intentions for January 2013
General Intention:
The Faith of Christians. That in this Year of Faith Christians may deepen their knowledge of the mystery of Christ and witness joyfully to the gift of faith in him.
Missionary Intention: Middle Eastern Christians. That the Christian communities of the Middle East, often discriminated against, may receive from the Holy Spirit the strength of fidelity and perseverance.

Keywords: AIDS, HIX, vaccine, trial studies, infection

NEWSLETTERS »

E-mail:       Zip Code: (ex. 90001)
Today's Headlines

Sign up for a roundup of the day's top stories. 5 days / week. See Sample

Rate This Article

Very Helpful Somewhat Helpful Not Helpful at All

Yes, I am Interested No, I am not Interested

Rate Article

1 - 1 of 1 Comments

  1. andrew
    10 months ago

    Such a vaccine will have similar effects as filtered cigarettes have on smokers.

Leave a Comment

Comments submitted must be civil, remain on-topic and not violate any laws including copyright. We reserve the right to delete any comments which are abusive, inappropriate or not constructive to the discussion.

Though we invite robust discussion, we reserve the right to not publish any comment which denigrates the human person, undermines marriage and the family, or advocates for positions which openly oppose the teaching of the Catholic Church.

This is a supervised forum and the Editors of Catholic Online retain the right to direct it.

We also reserve the right to block any commenter for repeated violations. Your email address is required to post, but it will not be published on the site.

We ask that you NOT post your comment more than once. Catholic Online is growing and our ability to review all comments sometimes results in a delay in their publication.

Send me important information from Catholic Online and it's partners. See Sample

Post Comment


Newsletter Sign Up